Hypnion, Inc.
500 Patriot Way
Lexington
Massachusetts
02421
U.S.A.
Phone:
781-778-0300
Fax:
781- 778-0303

|
Hypnion, Inc. is a recently founded, privately-held, biotechnology discovery company whose objective is to become the worldwide leader in sleep/wake neurobiology with the ultimate goal of understanding and being able to treat a wide range of sleep-wake disorders (e.g., insomnia, sleep apnea, excessive sleepiness, sleep-related dystonias) and circadian rhythm abnormalities (e.g., jet-lag, shift-work disorders, delayed or advanced sleep phase syndrome). The technology platform assembled for this includes the creation and molecular analysis of mouse models, genetic and genomic based target discovery, a high-throughput in vivo sleep-wake & physiological assay system, and the ability to quickly and efficiently screen pre-clinical compounds for sleep-wake effects or side effects. Additionally, this platform can be applied in many additional areas of CNS for corporate alliances.
Key Management:
Dale M. Edgar, Ph.D.
Founder
Karen Moore, Ph.D.
Founder
James F. White, Ph.D.
Chief Operating Officer and Executive Vice President of Research & Development
John F. Dee
President and Chief Executive Officer
Last Updated: 11-01-04
Email:
Ownership:
Private
Web Site:
Hypnion, Inc.
Employees:
Symbol:
|